Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Larson

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Future Oncology (London, England)|September 12, 2019
REPLATINUM Phase III randomized study: RRx-001 + platinum doublet versus platinum doublet in third-line small cell lung cancerBryan Oronsky, Tony R Reid, Christopher Larson, et al.
Clinical Medicine Insights. Oncology|November 15, 2016
A Partial Response to Reintroduced Chemotherapy in a Resistant Small Cell Lung Cancer Patient After Priming with RRx-001Bryan Oronsky, Scott Caroen, Karen Zeman, et al.
The Journal of the American Academy of Orthopaedic Surgeons|June 11, 2019
Best Practice Guidelines for Hip Arthroscopy in Femoroacetabular Impingement: Results of a Delphi ProcessT Sean Lynch, Anas Minkara, Stephen Aoki, et al.
Future Oncology (London, England)|August 11, 2022
BETA PRIME: Phase I study of AdAPT-001 as monotherapy and combined with a checkpoint inhibitor in superficially accessible, treatment-refractory solid tumorsSantosh Kesari, Alberto Bessudo, Brian R Gastman, et al.
Cancer Gene Therapy|December 25, 2023
BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumorsAnthony P Conley, Christina L Roland, Alberto Bessudo, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2011
Discovery of a new class of glucosylceramide synthase inhibitorsElena Koltun, Steven Richards, Vicky Chan, et al.
Orthopaedic Journal of Sports Medicine|February 17, 2023
The Use of Biologics in NFL Athletes: An Expert Consensus of NFL Team PhysiciansIain R Murray, Timothy R McAdams, Kyle E Hammond, et al.
The American Journal of Sports Medicine|June 29, 2018
Randomized Controlled Trial of Hip Arthroscopy Surgery vs Physical Therapy: Letter to the EditorScott C Faucett, Jeffrey J Nepple, Tony Andrade, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Future Oncology (London, England)|September 12, 2019
REPLATINUM Phase III randomized study: RRx-001 + platinum doublet versus platinum doublet in third-line small cell lung cancerBryan Oronsky, Tony R Reid, Christopher Larson, et al.
Clinical Medicine Insights. Oncology|November 15, 2016
A Partial Response to Reintroduced Chemotherapy in a Resistant Small Cell Lung Cancer Patient After Priming with RRx-001Bryan Oronsky, Scott Caroen, Karen Zeman, et al.
The Journal of the American Academy of Orthopaedic Surgeons|June 11, 2019
Best Practice Guidelines for Hip Arthroscopy in Femoroacetabular Impingement: Results of a Delphi ProcessT Sean Lynch, Anas Minkara, Stephen Aoki, et al.
Future Oncology (London, England)|August 11, 2022
BETA PRIME: Phase I study of AdAPT-001 as monotherapy and combined with a checkpoint inhibitor in superficially accessible, treatment-refractory solid tumorsSantosh Kesari, Alberto Bessudo, Brian R Gastman, et al.
Cancer Gene Therapy|December 25, 2023
BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumorsAnthony P Conley, Christina L Roland, Alberto Bessudo, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2011
Discovery of a new class of glucosylceramide synthase inhibitorsElena Koltun, Steven Richards, Vicky Chan, et al.
Orthopaedic Journal of Sports Medicine|February 17, 2023
The Use of Biologics in NFL Athletes: An Expert Consensus of NFL Team PhysiciansIain R Murray, Timothy R McAdams, Kyle E Hammond, et al.
The American Journal of Sports Medicine|June 29, 2018
Randomized Controlled Trial of Hip Arthroscopy Surgery vs Physical Therapy: Letter to the EditorScott C Faucett, Jeffrey J Nepple, Tony Andrade, et al.
Pageof 5